Published in Medical Letter on the CDC and FDA, June 22nd, 2008
"We are thrilled that the CereTom has cleared Korean FDA," said Eric M. Bailey, CEO and President of NeuroLogica Corporation. "South Korea is one of the most innovative and medically advanced countries in Asia, we are confident that the CereTom will improve the standard of care for critically ill patients with neurological emergencies. Our distribution partner, Dong Kang, Co. has an excellent reputation at the best medical institutions...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.